These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12852825)

  • 61.
    Choi YE; Yang JM; Jeong CW; Shin S; Park J; Lee K; Cho JH
    Pharmaceuticals (Basel); 2024 Jul; 17(7):. PubMed ID: 39065776
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prostacyclin Synthesis and Prostacyclin Receptor Expression in the Porcine Myometrium: Prostacyclin Potential to Regulate Fatty Acid Transporters, Cytokines and Contractility-Related Factors.
    Blitek A; Luba M; Szymanska M
    Animals (Basel); 2022 Aug; 12(17):. PubMed ID: 36077955
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension.
    Viswanathan G; Mamazhakypov A; Schermuly RT; Rajagopal S
    Front Cardiovasc Med; 2018; 5():179. PubMed ID: 30619886
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts.
    Cutolo M; Ruaro B; Montagna P; Brizzolara R; Stratta E; Trombetta AC; Scabini S; Tavilla PP; Parodi A; Corallo C; Giordano N; Paolino S; Pizzorni C; Sulli A; Smith V; Soldano S
    Arthritis Res Ther; 2018 May; 20(1):77. PubMed ID: 29720235
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stimulation of fat storage by prostacyclin and selective agonists of prostanoid IP receptor during the maturation phase of cultured adipocytes.
    Khan F; Syeda PK; Nartey MN; Rahman MS; Islam MS; Nishimura K; Jisaka M; Shono F; Yokota K
    Cytotechnology; 2016 Dec; 68(6):2417-2429. PubMed ID: 26946143
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Endogenous synthesis of prostacyclin was positively regulated during the maturation phase of cultured adipocytes.
    Rahman MS; Khan F; Syeda PK; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K
    Cytotechnology; 2014 Aug; 66(4):635-46. PubMed ID: 23884720
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn.
    Majed BH; Khalil RA
    Pharmacol Rev; 2012 Jul; 64(3):540-82. PubMed ID: 22679221
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products.
    Félétou M; Huang Y; Vanhoutte PM
    Br J Pharmacol; 2011 Oct; 164(3):894-912. PubMed ID: 21323907
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension.
    Falcetti E; Hall SM; Phillips PG; Patel J; Morrell NW; Haworth SG; Clapp LH
    Am J Respir Crit Care Med; 2010 Nov; 182(9):1161-70. PubMed ID: 20622039
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The PPARbeta/delta agonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension.
    Harrington LS; Moreno L; Reed A; Wort SJ; Desvergne B; Garland C; Zhao L; Mitchell JA
    PLoS One; 2010 Mar; 5(3):e9526. PubMed ID: 20209098
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protein kinases A and C regulate receptor-mediated increases in cAMP in rabbit erythrocytes.
    Adderley SP; Sridharan M; Bowles EA; Stephenson AH; Ellsworth ML; Sprague RS
    Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H587-93. PubMed ID: 20008267
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues.
    Falcetti E; Flavell DM; Staels B; Tinker A; Haworth SG; Clapp LH
    Biochem Biophys Res Commun; 2007 Sep; 360(4):821-7. PubMed ID: 17624303
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer.
    Daikoku T; Wang D; Tranguch S; Morrow JD; Orsulic S; DuBois RN; Dey SK
    Cancer Res; 2005 May; 65(9):3735-44. PubMed ID: 15867369
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prostacyclin-dependent apoptosis mediated by PPAR delta.
    Hatae T; Wada M; Yokoyama C; Shimonishi M; Tanabe T
    J Biol Chem; 2001 Dec; 276(49):46260-7. PubMed ID: 11551955
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardioprotective prostacyclin signaling in vascular smooth muscle.
    Fetalvero KM; Martin KA; Hwa J
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):109-18. PubMed ID: 17164138
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling.
    Mix KS; Coon CI; Rosen ED; Suh N; Sporn MB; Brinckerhoff CE
    Mol Pharmacol; 2004 Feb; 65(2):309-18. PubMed ID: 14742672
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multiple signalling options for prostacyclin.
    Wise H
    Acta Pharmacol Sin; 2003 Jul; 24(7):625-30. PubMed ID: 12852825
    [TBL] [Abstract][Full Text] [Related]  

  • 78. PPAR delta functions as a prostacyclin receptor in blastocyst implantation.
    Lim H; Dey SK
    Trends Endocrinol Metab; 2000; 11(4):137-42. PubMed ID: 10754535
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.